Vilobelimab
Product Specifications
CAS Number
2250440-41-4
Target
SARS-CoV|||Complement System
Related Pathways
Immunology/Inflammation|||Microbiology/Virology
Purity
0.99
Bioactivity
Vilobelimab (CaCP-29) is a human-mouse chimeric IgG antibody targeting human complement component 5a, a C5a inhibitor that inhibits neutrophil activation, and can be used for the study of systemic inflammation caused by SARS-CoV-2 infection.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx620192-01 100 µg
Human Low Affinity Immunoglobulin Gamma Fc Region Receptor III-B (FCGR3B) Protein
Ask
View Details abx620192-02 1 mg
Human Low Affinity Immunoglobulin Gamma Fc Region Receptor III-B (FCGR3B) Protein
Ask
View Details 
RC219020L3V 200 µL
CSB (ERCC6) (NM_000124) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details